Loading clinical trials...
Loading clinical trials...
Benign and malignant hematologic diseases are relatively rare conditions within the spectrum of medical practice in any one site of care. Nonetheless, recent research in hematologic conditions from ba...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ASH Research Collaborative
NCT06953960 · Multiple Myeloma
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT06818266 · Sickle Cell Disease, Acute Chest Syndrome
NCT01676805 · Hodgkin Disease, Lymphoma, Non-Hodgkin, and more
NCT05892393 · Multiple Myeloma, Plasma Cell Myeloma
ASH Research Collaborative
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions